Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Der Schmerz
Erschienen in: Der Schmerz 2/2016

17.03.2016 | Opioide | CME

Luftnot, Jucken und Depression in der Palliativmedizin

verfasst von: Dr. M. Mücke, R. Conrad, M. Bleckwenn, H. Cuhls, L. Radbruch, R. Rolke

Erschienen in: Der Schmerz | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Zusammenfassung

Palliativmedizin zielt auf eine Verbesserung der Lebensqualität durch Linderung belastender Symptome. Zu den häufigsten Symptomen zählen hier Schwäche, Schmerzen, Appetitmangel und Übelkeit, aber auch Luftnot, Jucken und Depressionen. Oft kann eine gute Symptomkontrolle mit der richtigen Medikamentenkombination oder durch nichtmedikamentöse Maßnahmen erreicht werden. Dieser Beitrag beschäftigt sich speziell mit den körperlichen Symptomen Luftnot und Jucken sowie mit der Depression als psychischem Symptom.
Literatur
1.
Aulbert E, Pichlmaier H, Albrecht H, Aulbert-Nauck-Radbruch (Hrsg) (2012) Lehrbuch der Palliativmedizin: mit 204 Tabellen, 3. Aufl. Schattauer, Stuttgart
2.
Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C et al (2011) Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 12(2):160–174CrossRefPubMed
3.
Irwin SA, Rao S, Bower K, Palica J, Rao SS, Maglione JE et al (2008) Psychiatric issues in palliative care: recognition of depression in patients enrolled in hospice care. J Palliat Med 11(2):158–163CrossRefPubMed
4.
Thomas S, Bausewein C, Higginson I, Booth S (2011) Breathlessness in cancer patients – implications, management and challenges. Eur J Oncol Nurs 15(5):459–469CrossRefPubMed
5.
Farquhar MC, Prevost AT, McCrone P, Brafman-Price B, Bentley A, Higginson IJ et al Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed-method randomised controlled trial. BMC Med. http://​www.​ncbi.​nlm.​nih.​gov/​pmc/​articles/​PMC4222435/​ (Erstellt: 31. Oktober 2014). Zugegriffen: 7. November 2015
6.
Powell B (2014) Managing breathlessness in advanced disease. Clin Med 14(3):308–311CrossRef
7.
Bausewein C, Booth S, Higginson IJ (2008) Measurement of dyspnoea in the clinical rather than the research setting. Curr Opin Support Palliat Care 2(2):95–99CrossRefPubMed
8.
Martin LL (1994) Validity and reliability of a quality-of-life instrument: the chronic respiratory disease questionnaire. Clin Nurs Res 3(2):146–156CrossRefPubMed
9.
Bausewein C, Booth S, Gysels M, Kühnbach R, Higginson IJ (2010) Effectiveness of a hand-held fan for breathlessness: a randomised phase II trial. BMC Palliat Care 9:22CrossRefPubMedPubMedCentral
10.
Booth S, Moffat C, Burkin J, Galbraith S, Bausewein C (2011) Nonpharmacological interventions for breathlessness. Curr Opin Support Palliat Care 5(2):77–86CrossRefPubMed
11.
Bausewein C, Booth S, Gysels M, Higginson I (2008) Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev. doi:10.1002/14651858.CD005623.pub2PubMed
12.
13.
Simon ST, Koskeroglu P, Gaertner J, Voltz R (2013) Fentanyl for the relief of refractory breathlessness: a systematic review. J Pain Symptom Manage 46:874–886. doi:10.1016/j.jpainsymman.2013.02.019
14.
Clark K, Currow DC (2013) Constipation in palliative care: What do we use as definitions and outcome measures? J Pain Symptom Manage 45(4):753–762CrossRefPubMed
15.
Smallwood N, Le B, Currow D, Irving L, Philip J (2015) Management of refractory breathlessness with morphine in patients with chronic obstructive pulmonary disease. Intern Med J 45(9):898–904CrossRefPubMed
16.
17.
Navigante AH, Cerchietti LCA, Castro MA, Lutteral MA, Cabalar ME (2006) Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer. J Pain Symptom Manage 31(1):38–47CrossRefPubMed
18.
Marciniuk DD, Goodridge D, Hernandez P, Rocker G, Balter M, Bailey P et al (2011) Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: A Canadian Thoracic Society clinical practice guideline. Can Respir J J. Can Thorac Soc 18(2):69–78
19.
Ripamonti C (1999) Management of dyspnea in advanced cancer patients. Support Care Cancer 7(4):233–243CrossRefPubMed
20.
21.
Simon ST, Köskeroglu P, Bausewein C (2012) Pharmacological therapy of refractory dyspnoea : a systematic literature review. Schmerz 26(5):515–522CrossRefPubMed
22.
Viola R, Kiteley C, Lloyd NS, Mackay JA, Wilson J, Wong RKS et al (2008) The management of dyspnea in cancer patients: a systematic review. Support Care Cancer 16(4):329–337CrossRefPubMed
23.
Currow DC, Ward AM, Abernethy AP (2009) Advances in the pharmacological management of breathlessness. Curr Opin Support Palliat Care 3(2):103–106CrossRefPubMed
24.
Kamal AH, Maguire JM, Wheeler JL, Currow DC, Abernethy AP (2012) Dyspnea review for the palliative care professional: treatment goals and therapeutic options. J Palliat Med 15(1):106–114CrossRefPubMedPubMedCentral
25.
Simon ST, Müller-Busch C, Bausewein DC (2010) Symptomatische Behandlung von Schmerzen und Atemnot. Internist 52(1):28–35CrossRef
26.
Seccareccia D, Gebara N (2011) Pruritus in palliative care: Getting up to scratch. Can Fam Physician 57(9):e316–e319PubMedCentral
27.
Ständer S, Steinhoff M, Schmelz M, Weisshaar E, Metze D, Luger T (2003) Neurophysiology of pruritus: cutaneous elicitation of itch. Arch Dermatol 139(11):1463–1470CrossRefPubMed
28.
Greaves MW (2005) Itch in systemic disease: therapeutic options. Dermatol Ther 18(4):323–327CrossRefPubMed
29.
30.
Ständer S (2011) Leitlinie Chronischer Pruritus. AWMF, Berlin
31.
Price A, Cohen DE (2014) Assessment of pruritus in patients with psoriasis and atopic dermatitis: subjective and objective tools. Dermatitis 25(6):334–344CrossRefPubMed
32.
Barnabé C, Daeninck P (2005) „Beauty is only skin deep“: prevalence of dermatologic disease on a palliative care unit. J Pain Symptom Manage 29(4):419–422CrossRefPubMed
33.
Oestmann A (2011) Vergessene Symptome bei Palliativpatienten. Palliativ-CH (2):5–7
34.
35.
Ruan X (2007) Drug-related side effects of long-term intrathecal morphine therapy. Pain Physician 10(2):357–366PubMed
36.
37.
Xander C, Meerpohl JJ, Galandi D, Buroh S, Schwarzer G, Antes G et al (2013) Pharmacological interventions for pruritus in adult palliative care patients. Cochrane Database Syst Rev 6:CD008320PubMed
38.
Hegade VS, Kendrick SFW, Jones DEJ (2015) Drug treatment of pruritus in liver diseases. Clin Med 15(4):351–357
39.
Siemens W, Xander C, Meerpohl JJ, Antes G, Becker G (2014) Drug treatments for pruritus in adult palliative care. Dtsch Arztebl Int 111(50):863–870PubMedPubMedCentral
40.
Ständer S, Weisshaar E, Raap U (2015) Emerging drugs for the treatment of pruritus. Expert Opin Emerg Drugs 20(3):515–521CrossRefPubMed
41.
Pfab F, Schalock PC, Napadow V, Athanasiadis GI, Yosipovitch G, Ring J (2013) Complementary integrative approach for treating pruritus. Dermatol Ther 26(2):149–156CrossRefPubMed
42.
43.
Ständer S, Grundmann SA (2012) Chronic pruritus. G Ital Dermatol Venereol 147(2):161–169PubMed
44.
Breitbart W, Rosenfeld B, Pessin H, Kaim M, Funesti-Esch J, Galietta M et al (2000) Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. JAMA 284(22):2907–2911CrossRefPubMed
45.
Brenne E, Loge JH, Kaasa S, Heitzer E, Knudsen AK, Wasteson E et al (2013) Depressed patients with incurable cancer: which depressive symptoms do they experience? Palliat Support Care 11(6):491–501CrossRefPubMed
46.
Radbruch L, Strasser F, Elsner F, Gonçalves JF, Løge J, Kaasa S et al (2008) Fatigue in palliative care patients – an EAPC approach. Palliat Med 22(1):13–32CrossRefPubMed
47.
Chochinov HM, Wilson KG, Enns M, Lander S (1997) „Are you depressed?“ Screening for depression in the terminally ill. Am J Psychiatry 154(5):674–676CrossRefPubMed
48.
Lloyd-Williams M, Spiller J, Ward J (2003) Which depression screening tools should be used in palliative care? Palliat Med 17(1):40–43CrossRefPubMed
49.
Rayner L, Price A, Hotopf M, Higginson IJ (1990) The development of evidence-based European guidelines on the management of depression in palliative cancer care. Eur J Cancer 47(5):702–712 (Mär)CrossRef
50.
51.
Lloyd-Williams M, Shiels C, Dowrick C (2007) The development of the Brief Edinburgh Depression Scale (BEDS) to screen for depression in patients with advanced cancer. J Affect Disord 99(1–3):259–264CrossRefPubMed
52.
Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J et al (1988) The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry 45(12):1069–1077CrossRefPubMed
53.
54.
Rayner L, Lee W, Price A, Monroe B, Sykes N, Hansford P et al (2011) The clinical epidemiology of depression in palliative care and the predictive value of somatic symptoms: cross-sectional survey with four-week follow-up. Palliat Med 25(3):229–241CrossRefPubMed
55.
Rodin G, Lo C, Mikulincer M, Donner A, Gagliese L, Zimmermann C (1982) Pathways to distress: the multiple determinants of depression, hopelessness, and the desire for hastened death in metastatic cancer patients. Soc Sci Med 68(3):562–569CrossRef
56.
Ujeyl M, Müller-Oerlinghausen B (2012) Antidepressants for treatment of depression in palliative patients : a systematic literature review. Schmerz 26(5):523–536CrossRefPubMed
57.
DGPPN, BÄK, KBV, AWMF, DEGAM (2009) Nationale S3 Leitlinie/Nationale Versorgungsleitlinie Unipolare Depression-Langfassung. AWMF, Berlin; Düsseldorf
58.
Rayner L, Price A, Evans A, Valsraj K, Hotopf M, Higginson IJ (2011) Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis. Palliat Med 25(1):36–51CrossRefPubMed
59.
Caruso R, Grassi L, Nanni MG, Riba M (2013) Psychopharmacology in psycho-oncology. Curr Psychiatry Rep 15(9):393CrossRefPubMed
60.
Kast RE, Foley KF (2007) Cancer chemotherapy and cachexia: mirtazapine and olanzapine are 5‑HT3 antagonists with good antinausea effects. Eur J Cancer Care (Engl) 16(4):351–354CrossRef
61.
Benkert O, Hippius H, Anghelescu I‑G (2014) Kompendium der Psychiatrischen Pharmakotherapie, 10. Aufl. Springer, Berlin, S 940
62.
Iglewicz A, Morrison K, Nelesen RA, Zhan T, Iglewicz B, Fairman N et al (2015) Ketamine for the treatment of depression in patients receiving hospice care: a retrospective medical record review of thirty-one cases. Psychosomatics 56(4):329–337CrossRefPubMed
63.
Fegg MJ (2006) Strategic Therapy in Palliative Care. Eur Psychother 6(1):271–308
64.
Breitbart W (2003) Reframing hope: meaning-centered care for patients near the end of life. Interview by Karen S. Heller. J Palliat Med 6(6):979–988CrossRefPubMed
65.
Breitbart W, Poppito S, Rosenfeld B, Vickers AJ, Li Y, Abbey J et al (2012) Pilot randomized controlled trial of individual meaning-centered psychotherapy for patients with advanced cancer. J Clin Oncol 30(12):1304–1309CrossRefPubMedPubMedCentral
66.
Chochinov HM, Hack T, Hassard T, Kristjanson LJ, McClement S, Harlos M (2005) Dignity therapy: a novel psychotherapeutic intervention for patients near the end of life. J Clin Oncol 23(24):5520–5525CrossRefPubMed
67.
Houmann LJ, Chochinov HM, Kristjanson LJ, Petersen MA, Groenvold M (2014) A prospective evaluation of Dignity Therapy in advanced cancer patients admitted to palliative care. Palliat Med 28(5):448–458CrossRefPubMed
68.
Akechi T, Okuyama T, Onishi J, Morita T, Furukawa TA (2008) Psychotherapy for depression among incurable cancer patients. Cochrane Database Syst Rev 2:CD005537PubMed
69.
Rhondali W, Yennurajalingam S, Ferrer J, Chisholm G, Filbet M, Bruera E (2014) Association between supportive care interventions and patient self-reported depression among advanced cancer outpatients. Support Care Cancer Off J. Support Care Cancer 22(4):871–879CrossRefPubMed
Metadaten
Titel
Luftnot, Jucken und Depression in der Palliativmedizin
verfasst von
Dr. M. Mücke
R. Conrad
M. Bleckwenn
H. Cuhls
L. Radbruch
R. Rolke
Publikationsdatum
17.03.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Der Schmerz / Ausgabe 2/2016
Print ISSN: 0932-433X
Elektronische ISSN: 1432-2129
DOI
https://doi.org/10.1007/s00482-016-0104-y

Weitere Artikel der Ausgabe 2/2016

Der Schmerz 2/2016 Zur Ausgabe

Originalien

Schmerzverlauf nach operativer orthopädischer Intervention

President's Corner (Mitteilungen der Deutschen Schmerzgesellschaft e. V.)

President's Corner (Mitteilungen der Deutschen Schmerzgesellschaft e. V.)

Originalien

Urologischen Patienten: Wie wirkt sich Angst vor der Op. auf den postoperativen Verlauf aus?

Übersichten

Maladaptive Plastizität bei chronischen und neuropathischen Schmerzen

Neues aus der Forschung

Schmerzmodulation durch kontextuelle Faktoren bei Masochisten

Originalien

Prüfungen im Querschnittsbereich Palliativmedizin (QB 13)